GINN Webinar Insights | 29 October 2026
Europe’s nicotine pouch market is expanding rapidly, but national differences in regulation are creating significant challenges for enforcement, manufacturers and consumers. Restrictions on legal access, widely varying tax rates and uncertainty over future EU rules have raised questions about how governments can maintain effective oversight of a growing product category.
These issues were examined during a GINN webinar on 29 October 2026, which brought together perspectives on illicit trade, manufacturing standards, product transparency and the role of nicotine pouches in tobacco harm reduction.
The discussion highlighted a central policy concern: restrictions intended to strengthen public health protection may have unintended consequences when consumer demand continues outside regulated markets.
Fragmented Regulation and the Growth of Illicit Trade
Nicotine pouches are subject to substantially different regulatory approaches across Europe. Some countries permit regulated sales, while others have introduced restrictions or prohibitions. Excise duties also differ considerably, creating price disparities that can encourage cross-border purchasing and unauthorised distribution.
Figures presented during the webinar placed the global nicotine pouch market at approximately US$10 billion, with an estimated 20 million users and annual growth of 44%. These estimates illustrate the scale of the market, although their methodology and reference periods require verification.
Germany was highlighted as an example of the challenges associated with restrictive market access. According to figures presented during the webinar, Germany ranked as the world’s ninth-largest nicotine pouch market in 2024, with an estimated market value of €168 million, consumption of 658 million pouches and approximately 614,000 adult users. France, which has also pursued restrictive measures, was estimated to have a €29 million market, with 114 million pouches consumed and around 200,000 adult users. These figures illustrate the scale of consumer demand despite restrictions on legal market access.
Finland offers a different perspective. Following changes that allowed nicotine pouches to be sold outside the earlier medicinal framework, illicit distribution reportedly continued to account for a substantial share of the market. A figure approaching 50% was cited during the discussion, although this should be assessed against the underlying research and the period covered.
These examples suggest that establishing legal access does not necessarily eliminate existing illicit supply networks. Enforcement, competitive pricing and consumer confidence in regulated products may all influence whether purchases move into legitimate channels.
Manufacturing Quality Depends on Regulatory Certainty
The webinar also examined the technical requirements of nicotine pouch manufacturing. Maintaining consistent nicotine content, pouch weight, moisture levels and other product characteristics requires reliable raw materials, controlled production processes and routine testing.
Manufacturers depend on suppliers of nicotine, cellulose, flavourings and pouch materials. Disruptions in these supply chains can affect product consistency and availability, making supplier diversification and effective quality assurance important considerations.
Traceability was identified as another essential requirement. Systems capable of linking raw materials, production batches, laboratory results and distribution records can support product recalls, compliance monitoring and investigations into quality concerns.
For manufacturers, predictable regulation is particularly important because investments in production equipment, laboratory testing and traceability systems often require long-term planning. The development of future EU rules, including possible revisions to the Tobacco Products Directive, therefore has implications for both commercial investment and regulatory oversight.
Why Product Transparency Matters
One initiative discussed was InterScientific’s PouchAware, which aims to make independently verified information about nicotine pouch products more accessible.
The initiative focuses on laboratory assessment of characteristics such as nicotine content, pouch weight, size, pH and nicotine release profiles. Making these results publicly available could help retailers, consumers and regulators better understand differences between products and assess whether manufacturers’ declarations are supported by testing.
Such information is particularly relevant in a market where products may differ considerably in composition and performance. Independent testing can contribute to more consistent standards, although laboratory findings must be interpreted carefully and do not, by themselves, establish a product’s long-term health effects or safety.
Innovation and the Risks of a Market Freeze
Speakers also raised concerns about proposals that could restrict further product development. A regulatory freeze on innovation might limit changes to legally marketed products while leaving unregulated suppliers free to introduce alternatives through informal channels.
This presents a potential enforcement challenge. If consumers seek product characteristics unavailable in the regulated market, restrictions could create additional incentives for illicit purchasing.
At the same time, innovation requires appropriate safeguards. Changes in nicotine delivery, formulation and product design should be subject to proportionate assessment, particularly where they could affect dependence, exposure or youth appeal.
A regulatory framework that permits evidence-based product development while maintaining clear standards may offer greater oversight than one that leaves emerging products outside established compliance systems.
Sweden’s Experience and Its Relevance to Europe
Sweden featured prominently in the discussion because of its comparatively low cigarette-smoking prevalence and longstanding availability of oral nicotine products, particularly snus.
Speakers argued that Sweden’s experience provides a useful reference for European policymakers considering the relationship between access to non-combustible nicotine products and smoking reduction.
However, Sweden’s outcomes cannot be attributed solely to nicotine pouches, which entered the market more recently than traditional snus. Historical tobacco-use patterns, public health measures, consumer preferences and other factors also need to be considered.
The Swedish experience nevertheless raises an important policy question: whether differentiated regulation, reflecting differences in risk between combustible and non-combustible products, could contribute to reducing smoking while maintaining appropriate consumer protections.
Towards a More Consistent European Framework
The webinar demonstrated how closely illicit trade, product quality and regulatory design are connected. Restricting legal access may reduce the visibility of products within regulated supply chains, while inconsistent national rules can complicate compliance and enforcement.
For EU policymakers, the challenge is to develop rules that address youth access, product safety and nicotine dependence without overlooking the consequences of persistent adult demand.
Greater consistency in product standards, independent testing, traceability and proportionate enforcement could help strengthen oversight. Further evidence is needed to determine which regulatory approaches are most effective at reducing illicit trade and improving public health outcomes.
As Europe considers the future of nicotine regulation, these questions deserve careful examination alongside the scientific evidence and practical experience of existing national frameworks.
